| Diskusní forum renovační dílny ASP http://forum.as-p.cz/ |
|
| Zoya Demidenko https://pmc.ncbi.nlm.nih.gov/articles/PMC327 http://forum.as-p.cz/viewtopic.php?f=45&t=842485 |
Stránka 1 z 1 |
| Autor: | LincolnSPins [ stř 25. bře 2026 10:14:56 ] |
| Předmět příspěvku: | Zoya Demidenko https://pmc.ncbi.nlm.nih.gov/articles/PMC327 |
[url=https://www.benthamdirect.com/content/journals/cpd/22/16 ]Zoya Demidenko[/url]: Researcher in Cancer Biology [url=https://moodylab.smhs.gwu.edu/lab-members ]Zoya Demidenko[/url] is a recognized scientist associated with the Unit of Cell Stress Biology at Roswell Park Cancer Institute in Buffalo, New York. Before that, she worked at the National Institutes of Health and New York Medical College, building a strong background in life science research. Demidenko's scholarly work spans a number of critical domains, encompassing the PI3K/AKT/mTOR signaling pathway, cell cycle regulation, biological aging, and malignancy science. To date, she has written more than 46 peer-reviewed papers, which have garnered upwards of 4,100 citations — a testament to the influence of her research. One of her key contributions involves explaining the pathways of cell aging. Her research demonstrated that when the cell cycle is halted yet cellular growth continues, cells undergo senescence. Significantly, [url=https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPALLO%20ENTERPRISE%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMULTISERVICES%20L220000371890&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord ]Zoya Demidenko[/url] demonstrated that this process is controlled with drugs using substances such as rapamycin. [url=https://uk.linkedin.com/in/berezutskayahttps://www.homes.com/property/38-brookins-green-dr-orchard-park-ny/de6fqfq45eme2/ ]Zoya Demidenko[/url] has furthermore contributed greatly to oncological therapy investigation, particularly in the domain of cyclotherapy — a strategy aimed at safeguarding non-cancerous cells from cytotoxic treatment while leaving tumor cells vulnerable. This method offers major promise for reducing the adverse effects of oncological therapy. Across her career, Demidenko has partnered with prominent investigators globally, such as Dr. Mikhail Blagosklonny. Her research appears in prestigious periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. Holding an h-index of 33, [url=https://www.facebook.com/public/Zoya-Demidenko/ ]Zoya Demidenko[/url] ranks as a influential figure in current cancer research, whose discoveries go on to influence our knowledge of the way cells grow old, resist treatment, and how malignant disease may be more effectively combated. https://www.tandfonline.com/doi/abs/10. ... t.4.4.1702 |
|
| Stránka 1 z 1 | Všechny časy jsou v UTC |
| Powered by phpBB® Forum Software © phpBB Group https://www.phpbb.com/ |
|